Prevalence of the metabolic syndrome and associated factors in Korean cancer survivors

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 3, 2013, Pages 1773-1780

  Lee, Jung Yun ^a   Park, Noh Hyun ^a   Song, Yong Sang ^a   Park, Sang Min ^a   Lee, Hae Won ^a   Kim, Kyae Hyung ^a   Choi, Kyung Hyun ^b  

^a Seoul National University College of Medicine   (South Korea)

^b Dongnam Institute of Radiological and Medical Science   (South Korea)

Author keywords

Cancer survivors; Korea; Metabolic syndrome; Prevalence; Risk factors

Indexed keywords

EID: 84880402572     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.3.1773     Document Type: Article

References (57)

1. Alberti KG, Eckel RH, Grundy SM, et al (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120, 1640-5.
2. Amling CL, Riffenburgh RH, Sun L, et al (2004). Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol, 22, 439-45.
3. Amparo P, Farr SL, Dietz PM (2011). Chronic disease risk factors among American Indian/Alaska Native women of reproductive age. Prev Chronic Dis, 8, A118.
4. Annaloro C, Usardi P, Airaghi L, et al (2008). Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant, 41, 797-804.
5. Ashrafian H, Ahmed K, Rowland SP, et al (2011). Metabolic surgery and cancer: protective effects of bariatric procedures. Cancer, 117, 1788-99.
6. Bae JM, Park JW, Yang HK, et al (1998). Nutritional status of gastric cancer patients after total gastrectomy. World J Surg, 22, 254-60; discussion 60-1.
7. Bechtold M, Palmer J, Valtos J, et al (2006). Metabolic syndrome in the elderly. Curr Diab Rep, 6, 64-71.
8. Befort CA, Klemp JR, Austin HL, et al (2012). Outcomes of a weight loss intervention among rural breast cancer survivors. Breast Cancer Res Treat, 132, 631-9.
9. Bo M, Sona A, Astengo M, et al (2009). Metabolic syndrome in older subjects: coincidence or clustering? Arch Gerontol Geriatr, 48, 146-50.
10. Boyle P, Levin B (2008). World cancer report 2008 Lyon, IARC Press.
11. Braga-Basaria M, Dobs AS, Muller DC, et al (2006). Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol, 24, 3979-83.
12. Brennan MF, Karpeh MS, JR (1996). Surgery for gastric cancer: the American view. Semin Oncol, 23, 352-9. Brown BW, Brauner C, Minnotte MC (1993). Noncancer deaths in white adult cancer patients. J Natl Cancer Inst, 85, 979-87.
13. Brown BW, Brauner C, Minnotte MC (1993). Noncancer deaths in white adult cancer patients. J Natl Cancer Inst, 85, 979-87.
14. Cabre JJ, Martin F, Costa B, et al (2008). Metabolic syndrome as a cardiovascular disease risk factor: patients evaluated in primary care. BMC Public Health, 8, 251.
15. Carey S, Storey D, Biankin AV, et al (2011). Long term nutritional status and quality of life following major upper gastrointestinal surgery - a cross-sectional study. Clin Nutr, 30, 774-9.
16. Chlebowski RT, Aiello E, Mctiernan A (2002). Weight loss in breast cancer patient management. J Clin Oncol, 20, 1128-43.
17. Erem C, Hacihasanoglu A, Deger O, et al (2008). Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study. Endocrine, 33, 9-20.
18. Follin C, Thilen U, Ahren B, et al (2006). Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. J Clin Endocrinol Metab, 91, 1872-5.
19. Ford ES, Giles WH, Dietz WH (2002). Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA, 287, 356-9.
20. Forootan M, Tabatabaeefar M, Yahyaei M, et al (2012). Metabolic syndrome and colorectal cancer:a crosssectional survey. Asian Pac J Cancer Prev, 13, 4999- 5002.
21. Gami AS, Witt BJ, Howard DE, et al (2007). Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol, 49, 403-14.
22. Grinker JA, Tucker K, Vokonas PS, et al (1995). Body habitus changes among adult males from the normative aging study: relations to aging, smoking history and alcohol intake. Obes Res, 3, 435-46.
23. Gurney JG, Ness KK, Sibley SD, et al (2006). Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer, 107, 1303-12.
24. Haskell WL, Lee IM, Pate RR, et al (2007). Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc, 39, 1423-34.
25. Haugnes HS, Aass N, Fossa SD, et al (2007). Components of the metabolic syndrome in long-term survivors of testicular cancer. Ann Oncol, 18, 241-8.
26. Jung HS, Myung SK, Kim BS, et al (2012). Metabolic Jung-Yun Lee et al 1780 syndrome in adult cancer survivors: a meta-analysis. Diabetes Res Clin Pract, 95, 275-82.
27. Jung KW, Park S, Kong HJ, et al (2011). Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat, 43, 1-11.
28. Korea Centers for Disease Control and Prevention (2010). The fourth Korean National Health and Nutrition Examination Survey [Online], Available from: http://knhanes.cdc. go.kr. [2012, Sepember 1]. [Online].
29. Kourti M, Tragiannidis A, Makedou A, et al (2005). Metabolic syndrome in children and adolescents with acute lymphoblastic leukemia after the completion of chemotherapy. J Pediatr Hematol Oncol, 27, 499-501.
30. Lechleitner M (2008). Obesity and the metabolic syndrome in the elderly--a mini-review. Gerontology, 54, 253-9.
31. Lehtonen R, Pahkinen E (2004). Practical methods for design and analysis of complex surveys (2nd ed.). Chichester, England: John Wiley and Sons.
32. Liavaag AH, Tonstad S, Pripp AH, et al (2009). Prevalence and determinants of metabolic syndrome and elevated Framingham risk score in epithelial ovarian cancer survivors: a controlled observational study. Int J Gynecol Cancer, 19, 634-40.
33. Meyerhardt JA, Catalano PJ, Haller DG, et al (2003). Influence of body mass index on outcomes and treatmentrelated toxicity in patients with colon carcinoma. Cancer, 98, 484-95.
34. Mohamud WN, Ismail A, Khir AS, et al (2011). Prevalence of metabolic syndrome and its risk factors in adult Malaysians: results of a nationwide survey. Diabetes Res Clin Pract, 96, 91-7.
35. National Cancer Information Center (2011). Cancer incidence [Online], Available from: http://www.cancer.go.kr/ncic/ cics_f/01/011/index.html. [2012, September 14].
36. National Cancer Institute (2012). SEER Cancer Statistics Review, 1975-2009 [Online], Available from: http://seer. cancer.gov/csr/1975_2009_pops09/. [2012, April 1].
37. Ness KK, Oakes JM, Punyko JA, et al (2005). Prevalence of the metabolic syndrome in relation to self-reported cancer history. Ann Epidemiol, 15, 202-6.
38. Nuver J, Smit AJ, Wolffenbuttel BH, et al (2005). The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol, 23, 3718-25.
39. Oeffinger KC, Mertens AC, Sklar CA, et al (2006). Chronic health conditions in adult survivors of childhood cancer. N Engl J Med, 355, 1572-82.
40. Park HS, Oh SW, Cho SI, et al (2004). The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol, 33, 328-36.
41. Park SM, Lim MK, Shin SA, et al (2006). Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol, 24, 5017-24.
42. Park YW, Zhu S, Palaniappan L, et al (2003). The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med, 163, 427-36.
43. Redig AJ, Munshi HG (2010). Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy. Am J Med, 123, 87 e1-6.
44. Riediger ND, Clara I (2011). Prevalence of metabolic syndrome in the Canadian adult population. CMAJ, 183, E1127-34.
45. Rodrigues AD, Theodoro H, Mendes KG, et al (2013). Factors associated with metabolic syndrome in climacteric women of southern Brazil. Climacteric, 16, 96-103.
46. Ronco, AL, De Stefani E. Deoneo-Pellegrini H, et al (2012). Diabetes, overweight and risk of postmenopausal breast cancer : a case-control study in Uruguay. Asian Pac J Cancer Prev, 13, 139-46.
47. Shin DW, Ahn E, Kim H, et al (2010a). Non-cancer mortality among long-term survivors of adult cancer in Korea: national cancer registry study. Cancer Causes Control, 21, 919-29.
48. Shin DW, Nam JH, Kwon YC, et al (2008). Comorbidity in disease-free survivors of cervical cancer compared with the general female population. Oncology, 74, 207-15.
49. Shin DW, Park JH, Park EC, et al (2010b). Antihypertensive medication adherence in cancer survivors and its affecting factors: results of a Korean population-based study. Support Care Cancer, 19, 211-20.
50. Talvensaari KK, Lanning M, Tapanainen P, et al (1996). Longterm survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab, 81, 3051-5.
51. Tayek JA, Heber D, Byerley LO, et al (1990). Nutritional and metabolic effects of gonadotropin-releasing hormone agonist treatment for prostate cancer. Metabolism, 39, 1314-9.
52. Trimis G, Moschovi M, Papassotiriou I, et al (2007). Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. J Pediatr Hematol Oncol, 29, 309- 14.
53. Ulaganathan V, Kandiah M, Zalilah MS, et al (2012). Colorectal cancer and its association with the metabolic syndrome:a Malaysian multi-centric case-control study. Asian Pac J Cancer Prev, 13, 3873-7.
54. Villareal DT, Apovian CM, Kushner RF, et al (2005). Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Obes Res, 13, 1849-63.
55. Visser M, Langlois J, Guralnik JM, et al (1998). High body fatness, but not low fat-free mass, predicts disability in older men and women: the Cardiovascular Health Study. Am J Clin Nutr, 68, 584-90.
56. Whiteman MK, Hillis SD, Curtis KM, et al (2005). Body mass and mortality after breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev, 14, 2009-14.
57. WHO/IASO/IOTF (2000). The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Melbourne: Health Communication, Australia. Pty Ltd.